Implantica AG

IMP-A-SDB · Nasdaq Stockholm · Healthcare

75.20SEK +1.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: +16.4%

Performance

1 month

+26.6%

1 year

+16.4%

3 years, per year

+53.5%

5 years, per year

−3.5%

Largest fall, 3 years

−90.4%

Below the peak now

−56.3%

Volatility, 1 year

51.2%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

5.9

Dividend yield

0.0%

Return on equity

−25.3%

Net margin

–

Market value

521 m USD

Quality, value and trend

Where Implantica stands against every Nordic stock today. 100 is best.

Quality73

Profitability and a sound balance sheet over time. Better than 73% of Nordic stocks.

Value5

The price measured against earnings, assets and cash flow. Better than 5% of Nordic stocks.

Trend81

The price development over the past year. Better than 81% of Nordic stocks.

Combined52

Quality, value and trend together. Better than 52% of Nordic stocks.

About Implantica

Implantica AG is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 46 employees.

Implantica AG engages in the research and distribution of medical implants in Switzerland and Spain. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system monitor, transmit, and actively treat conditions from within the body; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis